• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Health

UCLA Health
  • About Us
    • What is UCLA Health?
    • Contact Us
    • Your Feedback
    • Accountable Care Organization
    • Awards & Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • Health Equity, Diversity & Inclusion
    • In the Community
    • Industry Relations
    • Innovation
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    • #TeamLA
    • 340B Program
    Vital SignsLinked Graphic: Subscribe to Health Newsletters
    • Contact
    • Your Feedback
    • Accountable Care Organization
    • Awards and Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • Health Equity, Diversity and Inclusion
    • Industry Relations
    • Innovation
    • In the Community
    • 340B Program
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    • TeamLA
    • Subscribe to UCLA Health Newsletters
  • Conditions & Treatment
    • Health Library
    • Tests & Procedures
    • Drug Interaction Checker
    • Brain & Nervous System
    • Cancer
    • Children's Health
    • Heart Disease
    • Nutrition & Wellness
    • Pregnancy & Newborns
    • Orthopedics
    • Women's Health
    • Video Library
    • Cancer
    • Cardiovascular
    • Chiropractic
    • Cosmetic Surgery
    • Ear, Nose and Throat
    • Gastrointestinal
    • General Healthcare
    • Neurological
    • Obstetrics/Gynecology
    • See all videos...
    Symptom Checker
    • Video Library
  • Locations

    Hospitals

    • Ronald Reagan UCLA Medical Center
    • UCLA Santa Monica Medical Center
    • UCLA Mattel Children's Hospital
    • Resnick Neuropsychiatric Hospital
    • Institutes and Centers
    • Take a Virtual Tour

    Medical Offices/Clinics

    • Primary Care
    • Specialty Care
    • Immediate Care
    • Emergency Care
    • Outpatient Surgery Centers
    • Community Cancer Care
    • Pediatric Locations
    • Imaging/Radiology
    • Clinical Labs
    • Pharmacies

    Interactive Map

    interactive map

    • Interactive Map
    • UCLA Medical Plazas
    • Locations Coming Soon
    • UCLA Hospitals
    • Take a Virtual Tour
    • Primary Care Practices
    • Specialty Care Practices
    • Immediate Care
    • Emergency Care
    • Pediatric Locations
    • Outpatient Surgery Centers
    • Clinical Labs
    • Pharmacies
    • Other Locations
    • Interactive Map
    • Coming Soon!
  • Medical Services
  • For Patients & Visitors
    • Directions & Parking
    • Appointments
    • Video Visits
    • Medical Chaperones
    • Admissions
    • Preparing For Surgery
    • Patient Services
    • Security & Parking Services
    • Office of the Patient Experience
    • For International Patients
    • Lodging & Nearby Services
    • Around Westwood
    • Gift Shops & Flowers
    • Patient Greeting Cards
    • Coronavirus Resources
    • Log in to myUCLAhealth
    • Billing and Insurance
    • Medical Records
    • Price Transparency
    • Health Encyclopedia
    • Interactive Patient Education Videos (Emmi)
    • FAQs
    • Calendar of Events
    • Secure Email Messages
    • Health Resources
    • Multimedia
    • Download our Apps
    • Doctor on video visit
    • Open Enrollment
    • Visit our Connect Blog
    • Send a Care Compliment
    • Read Health Publications
    • Vital Signs Newsletters
    • Join a Patient and Family Advisory Council
    • Share your Feedback
    • Contact Us
    • Appointments: Call, Click, Come in
    • Video Visits - Telemedicine
    • Medical Chaperones
    • Admissions Information
    • Advance Directive
    • Directions & Parking
    • Patient Services
    • Medical Records
    • myUCLAhealth
    • Smoke-Free
    • Publications
    • Multimedia
    • Health Resources
    • Around Westwood
    • Lodging
    • Preparing For Surgery
    • Patient-focused Technology Council
    • Health Forms
    • End of Life Option Act: Resources & Materials
    • Frequently Asked Questions
    • Secure Email Messages
    • Gift Shops
    • Patient Greeting Cards
  • For Healthcare Professionals
    • Referring a Patient
    • Continuing Medical Education
    • Ethics Center
    • UCLA HealthLink
    • Physician to Physician Access Line (P2P)
    • David Geffen School of Medicine at UCLA
    • Clinical Informatics Fellowship
    • Academic Positions
    • Physician Careers
    • UCLA School of Dentistry
    • UCLA School of Nursing
    • Department of Nursing

    Physician Publications

    • Physicians Update
    • Clinical Updates
    • U Magazine
    • Physician to Physician Access Line (P2P)
    • Physician Careers
    • Clinical Informatics Fellowship
    • Flu Resources for Healthcare Professionals
    • Publications
  • Clinical Research
    • All Clinical Trials
    • COVID-19 Clinical Research
  • Find a Provider
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

News Releases

  1. Home
  2. About Us
  3. News Releases

News Releases

Health and Behavior

UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19

04/02/2020
Woman scientist in laboratory

UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate anti-viral drug against COVID-19.

The drug, called remdesivir, was originally developed as a treatment for Ebolavirus. Although found to be safe, it was not effective in treating those patients. However, in laboratory tests it appears to work against the SARS-CoV-2, which causes COVID-19, raising hope for its efficacy against this new, novel virus that has swept the globe, sickening and killing thousands. At its worst, the disease attacks the lung in particularly vulnerable people. People age 60 and older who have other health issues are especially susceptible to the disease's most severe effects and are likeliest to die from it.

This evidence has initiated formal investigations into the efficacy of the drug such as the one launched by the NIH through its National Institute of Allergy and Infectious Diseases. UCLA, an academic medical center at the forefront of health research, is part of this and trials of other drugs to fight the virus – with others potentially launching soon.

Dr. Otto Yang, professor of medicine, division of infectious diseases, at the David Geffen School of Medicine at UCLA, is leading this trial, with substantial support from the UCLA Clinical and Translational Science Institute.

"Remdesivir is a drug that has good activity against the virus in lab experiments, and it seems to effectively treat similar viruses in animals," said Yang, who is also a professor of microbiology, immunology & molecular genetics at the Geffen School. "We don't know yet whether it is effective in humans with COVID-19 so it is undergoing clinical tests in patients."

There are a few big trials underway in China and the U.S. combining data from many patients at various medical facilities, with UCLA being one of the sites for one of the biggest trials, he noted. Patients are offered enrollment if they have known COVID-19, are admitted to the hospital and have moderate or worse illness. The trial is placebo-controlled, meaning that half of patients get the actual drug and half get a placebo, or substance that has no therapeutic effect. It is also double-blind, meaning that the researchers do not know which patients are getting the drug or placebo, thus preventing any intentional or unintentional bias.

Placebo-controlled trials are necessary to maintain the integrity of the findings. And it is important to note that there are now no known effective treatments against COVID-19, Yang said. Participants who receive the placebo are contributing as much to the fight against COVID-19 as those getting the actual drug.

"So, participating in a trial is really about figuring out what might work, and it is a valuable contribution to helping science and developing useful treatments for the future," Yang said. "Receiving the placebo is just as important as receiving the drug from this standpoint, when we don't know if an experimental treatment has a benefit at all."

This is only one of several trials of different agents under investigation at UCLA to use against the disease, said Dr. Judith Currier, chief of the UCLA Division of Infectious Diseases at the Geffen School.

Currier and Dr. Arash Naeim, chief medical officer for clinical research for UCLA Health, are co-chairs of a clinical research task force that is coordinating these studies across multiple units on campus, such as the UCLA Clinical and Translational Science Institute and the UCLA Fielding School of Public Health.

For instance, one trial is examining sarilumab, a treatment for rheumatoid arthritis.

"There are several more trials expected soon as we work to evaluate promising therapies including biologics, antivirals and immune-based treatments for people with different stages of COVID disease," Currier said.

Click here for all COVID-19 clinical trials at UCLA >



Media Contact
Enrique Rivero
310-267-7120
ERivero@mednet.ucla.edu



Latest News

Health and Behavior
UCLA shares COVID-19 vaccine information with faculty and staff
01/15/2021
Members of the COVID-19 Response and Recovery Task Force updated faculty and staff on the progress of UCLA Health's vaccination program and to take questions.

Health and Behavior
In lab study, nanoparticle shows promising results for treating severe allergies
01/14/2021
A UCLA research team developed a possible way to impart long-term relief by inducing an active state of immune tolerance.

Health and Behavior
Cancer researchers awarded grant to study genomic alterations in prostate cancer
01/12/2021
Paul Boutros, PhD, Robert Reiter, MD, and Huihui Ye, MD, MS, of the UCLA Jonsson Comprehensive Cancer Center have received the 2020 Prostate Cancer Foundation Special Challenge Award to help improve the understanding of prostate cancer biology and identify new ways to help prevent, diagnose, prognose and treat lethal prostate cancer.

Health and Behavior
UCLA scientists develop method to more efficiently isolate and identify rare T cells
01/11/2021
Scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a technique that will enable researchers to more efficiently isolate and identify rare T cells that are capable of targeting viruses, cancer and other diseases.

Health and Behavior
MRI frequently underestimates tumor size in prostate cancer
01/07/2021
Research brief: Improving imaging processes will lead to more successful treatments and help reduce morbidity in men with the disease.

Facebook Twitter Instagram Youtube LinkedInWeibo
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap

Sign in to myUCLAhealth

Learn more about myUCLAhealth